Use access key #2 to skip to page content.
$3.46 -0.19 (-5.21%)
5/16/2008 3:41 PM

XTENT, Inc. (XTNT)

CAPS Rating:
*

A development stage medical device company, which focused on developing and commercializing its customizable drug eluting stent systems for the treatment of coronary artery disease or CAD.

View All Commentary (XTNT)

Recs

0

Avatar nguyenvanh (< 20) Submitted: 6/29/07 5:24 PM : Outperform Start Price: $10.07 XTNT Score: -60.20

Strong cash. High potential.

Report this Post Replies: 0 | Reply

Featured Broker Partners